Research and Markets: China Avian Influenza Vaccine Industry Research Report 2014-2018

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/69h9rq/research_report) has announced the addition of the "Research Report on China Avian Influenza Vaccine Industry, 2014-2018" report to their offering.

Many countries choose to kill all infected poultry to control avian influenza, instead of immunizations. The total number of poultry exceeds 10 billion in China. Epidemic diseases, which are difficult to control, will result in huge losses. Therefore, it is quite necessary to immunize the poultry with avian influenza vaccines.

Avian influenza vaccines have been used for more than 10 years in China. Some poultry farms in China began to use H5N1 avian influenza vaccines voluntarily 10 years ago without compulsory requirements. Chinese avian influenza vaccine industry was in the initial stage in 2001-2005 with upcoming problems. To resolve these problems, the Ministry of Agriculture of China sets up an entry barrier for the avian influenza vaccine production and imposes strict supervision. The Ministry of Agriculture of China established strict regulations on the production and sales of avian influenza vaccines. For instance, avian influenza vaccines must be produced in workshops that are in compliance with GMP and inspected every year.

In China, the subsidy provided by the government over killing the infected poultry is CNY 10 per bird. In case of serious epidemic diseases, the subsidy amount will be higher.

In 2013, the live stock volume of laying hens in China was about 1.4 billion while that of broilers was approximately 10 billion. The output volume of eggs in China was 28.76 million tons in 2013, up by 0.5% YOY. According to National Compulsory Immunization Plan of Animal Epidemic Diseases 2013 issued by Ministry of Agriculture of China, the government conducts compulsory immunizations against 4 diseases, including highly pathogenic avian influenza. The government is responsible for the expenses. In 2013, the market size of avian influenza vaccines exceeded CNY 1 billion in China.

Key Topics Covered:

1 Status of Global and China Avian Influenza Vaccine Markets

2 Factors Influencing Development of China Avian Influenza Vaccine Industry, 2012-2013

3 Operation Status of China Avian Influenza Vaccine Industry, 2009-2013

4 Major Manufacturers of Avian Influenza Vaccines in China, 2012-2013

5 Status of Avian Influenza Vaccines Purchase by Some Local Governments in China, 2013

6 Prospect of China Avian Influenza Vaccine Industry, 2014-2018

Companies Mentioned

- Guangdong Winsun Pharmaceutical Co., Ltd.

- Harbin Pharmaceutical Group Biological Vaccines Co., Ltd.

- Harbin Weike Biotechnology Development Company

- Liaoning Yikang Biology Co., Ltd.

- Merial Nanjing Animal Health Co., Ltd.

- QYH Biotech Company Limited

- Qingdao Yebio Bioengineering Co., Ltd.

- Shandong Sinder Technology Co., Ltd.

- Zhaoqing Dahuanong Animal Health Products Co., Ltd.

For more information visit http://www.researchandmarkets.com/research/69h9rq/research_report

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Animal Healthcare/Veterinary

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Animal Healthcare/Veterinary